These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 19783773)

  • 1. Differential regulation of vascular smooth muscle and endothelial cell proliferation in vitro and in vivo by cAMP/PKA-activated p85alphaPI3K.
    Torella D; Gasparri C; Ellison GM; Curcio A; Leone A; Vicinanza C; Galuppo V; Mendicino I; Sacco W; Aquila I; Surace FC; Luposella M; Stillo G; Agosti V; Cosentino C; Avvedimento EV; Indolfi C
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2015-25. PubMed ID: 19783773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway.
    Zhu Q; Ni XQ; Lu WW; Zhang JS; Ren JL; Wu D; Chen Y; Zhang LS; Yu YR; Tang CS; Qi YF
    Atherosclerosis; 2017 Nov; 266():212-222. PubMed ID: 29053988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of the Ras-extracellular signal-regulated kinase 1/2 pathway is involved in smooth muscle 22 alpha-mediated suppression of vascular smooth muscle cell proliferation and neointima hyperplasia.
    Dong LH; Wen JK; Liu G; McNutt MA; Miao SB; Gao R; Zheng B; Zhang H; Han M
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):683-91. PubMed ID: 20139360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfur dioxide inhibits vascular smooth muscle cell proliferation via suppressing the Erk/MAP kinase pathway mediated by cAMP/PKA signaling.
    Liu D; Huang Y; Bu D; Liu AD; Holmberg L; Jia Y; Tang C; Du J; Jin H
    Cell Death Dis; 2014 May; 5(5):e1251. PubMed ID: 24853429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin S Activity Controls Injury-Related Vascular Repair in Mice via the TLR2-Mediated p38MAPK and PI3K-Akt/p-HDAC6 Signaling Pathway.
    Wu H; Cheng XW; Hu L; Takeshita K; Hu C; Du Q; Li X; Zhu E; Huang Z; Yisireyili M; Zhao G; Piao L; Inoue A; Jiang H; Lei Y; Zhang X; Liu S; Dai Q; Kuzuya M; Shi GP; Murohara T
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1549-57. PubMed ID: 27365406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential phosphoinositide 3-kinase signaling: implications for PTCA?
    Rocic P
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H1970-1. PubMed ID: 19837947
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of vascular smooth muscle cell proliferation and injury-induced neointimal hyperplasia by CREB-mediated p21 induction: An insight from a plant polyphenol.
    Sun L; Zhao R; Zhang L; Zhang W; He G; Yang S; Song J; Du G
    Biochem Pharmacol; 2016 Mar; 103():40-52. PubMed ID: 26807478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered S-phase kinase-associated protein-2 levels are a major mediator of cyclic nucleotide-induced inhibition of vascular smooth muscle cell proliferation.
    Wu YJ; Bond M; Sala-Newby GB; Newby AC
    Circ Res; 2006 May; 98(9):1141-50. PubMed ID: 16574903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CREB-mediated IL-6 expression is required for 15(S)-hydroxyeicosatetraenoic acid-induced vascular smooth muscle cell migration.
    Chava KR; Karpurapu M; Wang D; Bhanoori M; Kundumani-Sridharan V; Zhang Q; Ichiki T; Glasgow WC; Rao GN
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):809-15. PubMed ID: 19342597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Janus Kinase 3, a Novel Regulator for Smooth Muscle Proliferation and Vascular Remodeling.
    Wang YC; Cui XB; Chuang YH; Chen SY
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1352-1360. PubMed ID: 28473442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEA-15 (Phosphoprotein Enriched in Astrocytes 15) Is a Protective Mediator in the Vasculature and Is Regulated During Neointimal Hyperplasia.
    Greig FH; Kennedy S; Gibson G; Ramos JW; Nixon GF
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28893763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed-lineage kinase 3 deficiency promotes neointima formation through increased activation of the RhoA pathway in vascular smooth muscle cells.
    Gadang V; Konaniah E; Hui DY; Jaeschke A
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1429-36. PubMed ID: 24790140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salt-Inducible Kinase 3 Promotes Vascular Smooth Muscle Cell Proliferation and Arterial Restenosis by Regulating AKT and PKA-CREB Signaling.
    Cai Y; Wang XL; Lu J; Lin X; Dong J; Guzman RJ
    Arterioscler Thromb Vasc Biol; 2021 Sep; 41(9):2431-2451. PubMed ID: 34196217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FAM3A promotes vascular smooth muscle cell proliferation and migration and exacerbates neointima formation in rat artery after balloon injury.
    Jia S; Chen Z; Li J; Chi Y; Wang J; Li S; Luo Y; Geng B; Wang C; Cui Q; Guan Y; Yang J
    J Mol Cell Cardiol; 2014 Sep; 74():173-82. PubMed ID: 24857820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling.
    Razuvaev A; Henderson B; Girnita L; Larsson O; Axelson M; Hedin U; Roy J
    J Vasc Surg; 2007 Jul; 46(1):108-15. PubMed ID: 17606126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of Methionine Sulfoxide Reductase A Does Not Affect Atherothrombosis but Promotes Neointimal Hyperplasia and Extracellular Signal-Regulated Kinase 1/2 Signaling.
    Klutho PJ; Pennington SM; Scott JA; Wilson KM; Gu SX; Doddapattar P; Xie L; Venema AN; Zhu LJ; Chauhan AK; Lentz SR; Grumbach IM
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2594-604. PubMed ID: 26449752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-24 attenuates vascular remodeling in diabetic rats through PI3K/Akt signaling pathway.
    Cai W; Zhang J; Yang J; Fan Z; Liu X; Gao W; Zeng P; Xiong M; Ma C; Yang J
    Nutr Metab Cardiovasc Dis; 2019 Jun; 29(6):621-632. PubMed ID: 31005375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tauroursodeoxycholate (TUDCA) inhibits neointimal hyperplasia by suppression of ERK via PKCα-mediated MKP-1 induction.
    Kim SY; Kwon YW; Jung IL; Sung JH; Park SG
    Cardiovasc Res; 2011 Nov; 92(2):307-16. PubMed ID: 21840882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphodiesterase 3A (PDE3A) deletion suppresses proliferation of cultured murine vascular smooth muscle cells (VSMCs) via inhibition of mitogen-activated protein kinase (MAPK) signaling and alterations in critical cell cycle regulatory proteins.
    Begum N; Hockman S; Manganiello VC
    J Biol Chem; 2011 Jul; 286(29):26238-49. PubMed ID: 21632535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of NAD(P)H:quinone oxidoreductase 1 prevents arterial restenosis by suppressing vascular smooth muscle cell proliferation.
    Kim SY; Jeoung NH; Oh CJ; Choi YK; Lee HJ; Kim HJ; Kim JY; Hwang JH; Tadi S; Yim YH; Lee KU; Park KG; Huh S; Min KN; Jeong KH; Park MG; Kwak TH; Kweon GR; Inukai K; Shong M; Lee IK
    Circ Res; 2009 Apr; 104(7):842-50. PubMed ID: 19229058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.